ABSTRACT
AIM: The aim of the study is to evaluate the efficacy of a nurse-led interdisciplinary programme based on healthy eating, physical exercise, and cognitive behavioural therapy applied to anthropometric and cardiovascular measures, which are related to obesity in short, medium, and long term. METHODS: We conducted a randomised controlled clinical trial with 74 obese and overweight participants (experimental group, n = 37; control group, n = 37). An interdisciplinary programme of 12 months was applied and coordinated by a nurse. Anthropometric and cardiovascular measures were taken at the pretest stage, every 6 months during the programme, and 1 year after it finished. RESULTS: A beneficial effect was found regarding all anthropometric parameters. Tests for weight (F3;207 = 93.27; P < .001) and body mass index (F3;207 = 89.95; P < .001) indicate efficacy of intervention: The experimental group had a weight loss of 7.2 kg (-8.3%) compared to a 0.9 kg (+1.0%) gained in the control group. Systolic (F3;207 = 37.06; P < .001) and diastolic (F3;216 = 57.31; P < .001) blood pressure improved greatly in the experimental group. Forced vital capacity was also increased (F2;138 = 15.51; P < .001). CONCLUSION: The interdisciplinary programme coordinated by nurses improved the health of participants, maintaining long-term effects.
Subject(s)
Cognitive Behavioral Therapy , Exercise , Obesity/prevention & control , Overweight/prevention & control , Practice Patterns, Nurses' , Adult , Blood Pressure , Body Mass Index , Body Weight , Female , Humans , Male , Middle Aged , Obesity/physiopathology , Overweight/physiopathology , Time Factors , Treatment Outcome , Weight LossABSTRACT
OBJECTIVE: Obesity is an entity of highly prevalent multifactorial origin with associated metabolic and psychological comorbidity, causing a negative impact on the quality of life of those who suffer from it. The objective is to evaluate the impact of an interdisciplinary program for nurse-led obesity on quality of life related to health and anxiety. METHODS: Randomized controlled clinical trial with a sample of 74 subjects diagnosed with obesity (EG: n=37; CG: n=37). The intervention consisted of a 12-month interdisciplinary program (with pre-test, 12month and 24month follow-up) coordinated by nurses. RESULTS: The anxiety analysis shows that there is no effect of the intervention on S-STAI (F2; 144=0.246; p=0.782), which has increased in both groups. However, there is an effect on T-STAI (F2; 144=8872; p<0.001), which only increases in the control group. The interdisciplinary program has significantly improved health-related quality of life (SF-36), both in physical health parameters as well as in mental health. CONCLUSION: The interdisciplinary program led by nursing professionals has improved the quality of life related to health and has prevented the increase of anxiety-trait in participants, maintaining the long-term effects.
Subject(s)
Anxiety/prevention & control , Comorbidity , Obesity/therapy , Psychiatric Nursing , Quality of Life/psychology , Adult , Depression/psychology , Female , Humans , Male , Middle Aged , Models, Statistical , Psychiatric Status Rating Scales , Surveys and Questionnaires , Time FactorsABSTRACT
INTRODUCTION: It is extensive scientific literature that has defined the metabolic syndrome as a precursor of cardiovascular disease. OBJECTIVES: To estimate the prevalence of metabolic syndrome and cardiovascular risk in the population of a basic health area of Murcia. METHODS: Cross sectional study population of the district health "The Esparragal" random sample of the population between 18 and 86 years living in the area. Personal history were collected and held a relevant clinical, anthropometric data and analytics for the estimation of Metabolic Syndrome and Cardiovascular Risk following criteria dictated by the current literature, adjusted for sex and age. RESULTS: The mean age of the study population was 59.34 ± 14.79 years, with 52.5% males. The overall prevalence of metabolic syndrome criteria World Health Organization is presented 36.8%, a figure increased under International Diabetes Ferderation recommendations to 58.2% and according to National Cholesterol Education Program, an estimated 53.5%. The presentation of this syndrome is slightly higher in men (54.1 versus 52.8 %), and in parallel with increasing age (p < 0.001). The prevalence of people at high risk of cardiovascular disease is 32.1 % (95 % CI 29.4 to 34.8), with 45.2 % (95% CI 41.2 to 49.2) in men and 17.6% (95% CI 14.4 to 20.8) in women. DISCUSSION: The prevalence of metabolic syndrome and cardiovascular risk in the study population is the highest found in Spain in population studies, indicating an invaluable population on which preventive measures.
Introducción: Es extensa la literatura científica que ha definido al síndrome metabólico como precursor de la enfermedad cardiovascular. Objetivos: Estimar la prevalencia de Síndrome Metabólico y Riesgo Cardiovascular en la población de una zona básica de salud de Murcia. Métodos: Estudio poblacional de corte transversal de la zona básica de salud "El Esparragal", muestra aleatoria de la población entre 18 y 86 años residentes en dicha zona. Se recogieron los antecedentes personales y se llevo a cabo una evaluación clínica, antropométrica y analítica pertinente para la estimación de Síndrome Metabólico y el Riesgo Cardiovascular siguiendo criterios dictados por la literatura actual, ajustados a sexo y edad. Resultados: La edad media de la población estudiada resultó de 59,34±14,79 años, siendo el 52,5% varones. La prevalencia global de Síndrome Metabólico según criterios Organización Mundial de la Salud es del 36,8% presenta, cifra incrementada bajo recomendaciones International Diabetes Ferderation a un 58,2% y según National Cholesterol Education Program, se estimó un 53,5%. La presentación de dicho síndrome es ligeramente superior en varones (54,1 frente al 52,8%), y aumentando paralelamente con la edad (p.
Subject(s)
Cardiovascular Diseases/epidemiology , Metabolic Syndrome/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Prevalence , Risk Assessment , Risk Factors , Spain/epidemiology , Urban Population , Young AdultABSTRACT
Introducción: Es extensa la literatura científica que ha definido al síndrome metabólico como precursor de la enfermedad cardiovascular. Objetivos: Estimar la prevalencia de Síndrome Metabólico y Riesgo Cardiovascular en la población de una zona básica de salud de Murcia Métodos: Estudio poblacional de corte transversal de la zona básica de salud "El Esparragal", muestra aleatoria de la población entre 18 y 86 años residentes en dicha zona. Se recogieron los antecedentes personales y se llevo a cabo una evaluación clínica, antropométrica y analítica pertinente para la estimación de Síndrome Metabólico y el Riesgo Cardiovascular siguiendo criterios dictados por la literatura actual, ajustados a sexo y edad. Resultados: La edad media de la población estudiada resultó de 59,34±14,79 años, siendo el 52,5% varones. La prevalencia global de Síndrome Metabólico según criterios Organización Mundial de la Salud es del 36,8% presenta, cifra incrementada bajo recomendaciones International Diabetes Ferderation a un 58,2% y según National Cholesterol Education Program, se estimó un 53,5%. La presentación de dicho síndrome es ligeramente superior en varones (54,1 frente al 52,8%), y aumentando paralelamente con la edad (p<0,001). La prevalencia de personas con riesgo alto de Enfermedad Cardiovascular es de 32,1% (IC 95%: 29,4-34,8), siendo de 45,2% (IC95%: 41,2-49,2) en hombres y de 17,6% (IC95%: 14,4-20,8) en mujeres. Discusión: La prevalencia de síndrome metabólico y riesgo cardiovascular en la población estudiada es de las más altas halladas en España en estudios poblacionales, lo que indica una población inestimable sobre la cual aplicar medidas preventivas (AU)
Introduction: It is extensive scientific literature that has defined the metabolic syndrome as a precursor of cardiovascular disease. Objectives: To estimate the prevalence of metabolic syndrome and cardiovascular risk in the population of a basic health area of Murcia Methods: Cross sectional study population of the district health "The Esparragal" random sample of the population between 18 and 86 years living in the area. Personal history were collected and held a relevant clinical, anthropometric data and analytics for the estimation of Metabolic Syndrome and Cardiovascular Risk following criteria dictated by the current literature, adjusted for sex and age. Results: The mean age of the study population was 59.34 ± 14.79 years, with 52.5% males. The overall prevalence of metabolic syndrome criteria World Health Organization is presented 36.8%, a figure increased underInternational Diabetes Ferderation recommendations to 58.2% and according to National Cholesterol Education Program, an estimated 53.5%. The presentation of this syndrome is slightly higher in men (54.1 versus 52.8 %), and in parallel with increasing age (p < 0.001). The prevalence of people at high risk of cardiovascular disease is 32.1 % (95 % CI 29.4 to 34.8), with 45.2 % (95% CI 41.2 to 49.2) in men and 17.6% (95% CI 14.4 to 20.8) in women. Discussion: The prevalence of metabolic syndrome and cardiovascular risk in the study population is the highest found in Spain in population studies, indicating an invaluable population on which preventive measures (AU)
